tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
ACRS
Aclaris Therapeutics
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding ACRS?
Track your performance easily
Link Broker

Aclaris Therapeutics (ACRS) Stock News & Sentiment

587 Followers
Aclaris Therapeutics Reports Positive Q3 2024 Milestones
Premium
Company Announcements
Aclaris Therapeutics Reports Positive Q3 2024 Milestones
3d ago
ACRS
ACRS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ACRS Earnings this Week: How Will it Perform?
6d ago
ACRS
Is ACRS a Buy, Before Earnings?
Premium
Pre-Earnings
Is ACRS a Buy, Before Earnings?
3M ago
ACRS
Aclaris Therapeutics Secures Deal with OMERS for OLUMIANT Royalties
Premium
Company Announcements
Aclaris Therapeutics Secures Deal with OMERS for OLUMIANT Royalties
4M ago
8K
ACRS
Aclaris Therapeutics Corporate Update Conference Call
Premium
Company Announcements
Aclaris Therapeutics Corporate Update Conference Call
6M ago
8K
ACRS
Board Changes Ahead of Aclaris Therapeutics Annual Meeting
Premium
Company Announcements
Board Changes Ahead of Aclaris Therapeutics Annual Meeting
8M ago
8K
ACRS
Aclaris Therapeutics Executive Team Undergoes Major Changes
Premium
Company Announcements
Aclaris Therapeutics Executive Team Undergoes Major Changes
9M ago
8K
ACRS
More ACRS News >

ACRS News on the Web

Aclaris Therapeutics Reports Positive Q3 2024 Milestones
TipRanks News
Neutral
Aclaris Therapeutics (ACRS) Reports Q3 Loss, Misses Revenue Estimates
Zacks
Neutral
Millennium Management LLC Reduces Stake in Aclaris Therapeutics Inc
Yahoo Finance
Neutral
Is BellRing Brands Stock Outpacing Its Medical Peers This Year?
Yahoo Finance
Neutral
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
Zacks
Neutral
Aclaris doses first subject in Phase IIa atopic dermatitis treatment trial
Clinical Trials Arena
Neutral
Aclaris Therapeutics’ ATI-2138: A Hold Rating Amidst Phase 2a Trials and Market Opportunity Assessment
TipRanks News
Neutral
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
ACRS
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACRS’s Media Buzz Sentiment?
2 articles about ACRS were published this week. In an average week, 1 articles are published.
    What is ACRS’s weekly average amount of articles?
    In an average week, 1 articles about ACRS are published.
      What is ACRS’s News Sentiment?
      50% of articles about ACRS were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        IMCRImmunocore Holdings
        S5YASigma Healthcare Ltd
        ALECAlector
        CRSPCrispr Therapeutics AG
        NEONeoGenomics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing